logo conference-reports

Conference Reports

При финансовой поддержке logo MSD Oncology

ASCO 2018—Chemotherapy unnecessary for majority of patients with ER-positive, HER2-negative, node-negative early breast cancer

As many as 69% of patients with breast cancer in this subset can be spared adjuvant chemotherapy with no effect on DFS.